S&P MidCap 400 Adds Krystal Biotech, Drops Taylor Morrison and Avonova
Krystal Biotech replaces two companies in the S&P MidCap 400 index following merger-driven constituent changes. S&P Dow Jones Indices will add Krystal Biotech (KRYS) to the S&P MidCap 400 index, replacing Taylor Morrison Home (TMHC) and Avonova (AVNS). The changes reflect